ML13210A016
| ML13210A016 | |
| Person / Time | |
|---|---|
| Site: | Turkey Point  |
| Issue date: | 07/29/2013 |
| From: | Binoy Desai NRC/RGN-II/DRS/PSB2 |
| To: | Nazar M Florida Power & Light Co |
| Linda K. Gruhler 404-997-4633 | |
| References | |
| EA-13-064, IA-2013-026 | |
| Download: ML13210A016 (4) | |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION REGION II 245 PEACHTREE CENTER AVENUE NE, SUITE 1200 ATLANTA, GEORGIA 30303-1257 July 29, 2013 EA-13-064 Mr. Mano Nazar Executive Vice President and Chief Nuclear Officer Florida Power and Light Company P.O. Box 14000 Juno Beach, FL 33408-0420
SUBJECT:
U.S. NUCLEAR REGULATORY COMMISSION OFFICE OF INVESTIGATIONS REPORT NUMBER 2-2012-035
Dear Mr. Nazar:
On March 22, 2013, the U.S. Nuclear Regulatory Commissions (NRC) Office of Investigations (OI) completed an investigation involving a contract employee at Florida Power and Light Companys (FPL) Turkey Point nuclear plant. The investigation reviewed the circumstances surrounding the contract employees attempt to subvert a random fitness for duty (FFD) drug screen test by submitting an adulterated urine sample.
Based on a review of the details of the investigation, the NRC has concluded that FPLs FFD program implementation and response to the incident was appropriate, and we plan no further action regarding this matter. In this case, FPLs FFD program provided reasonable assurance that individuals are not under the influence of any legal or illegal substance, and provided reasonable assurance for early detection of individuals who are not fit to perform their duties, in accordance with applicable regulatory requirements of Title 10 of the Code of Federal Regulations (10 CFR) Part 26. In addition, FPL conducted a review of the individuals work history at the Turkey Point facility, entered the individuals information into the Personnel Access Data System (PADS) following the event, and promptly terminated the individuals unescorted access to the Turkey Point nuclear plant. The NRC also notes FPLs compliance with 10 CFR Part 26.75(b), which states that any act or attempted act to subvert the testing process, including an attempt to provide a substituted or adulterated specimen, for any test required under 10 CFR 26.31(c), must result in the immediate unfavorable termination of unescorted authorization and permanent denial of authorization thereafter.
As a result of the NRCs review of the investigation, escalated enforcement action was taken against the individual. This action may be found in the NRC Public Document Room, or from the Publicly Available Records (PARS) component of NRC's Agencywide Documents Access
M. Nazar 2
and Management System (ADAMS), accessible from the NRC Web site at http://www.nrc.gov/NRC/ADAMS/index.html (the Public Electronic Reading Room), accession number ML13204A114.
In accordance with 10 CFR 2.390 of the NRC's "Rules of Practice," a copy of this letter will be available electronically for public inspection in the NRC Public Document Room, or in ADAMS.
Should you have any questions concerning this letter, please contact us at 404-997-4519.
Sincerely,
/RA/
Binoy Desai, Chief Plant Support Branch 2 Division of Reactor Safety Docket Nos. 50-250, 50-251 License Nos. DPR-31, DRP-41 cc: (See page 3)
ML13210A016 X SUNSI REVIEW COMPLETE X FORM 665 ATTACHED OFFICE RII:DRS/PSB2 RII:EICS RII:DRS/PSB2 SIGNATURE JHW2 CFE BBD NAME J. Wallo C. Evans B. Desai DATE 7/ 24 /2013 7/ 24 /2013 7/ 24 /2013 E-MAIL COPY YES NO YES NO YES NO
M. Nazar 3
cc:
Michael Kiley Site Vice President Turkey Point Nuclear Plant Florida Power and Light Company 9760 SW 344th Street Florida City, FL 33035 Robert J. Tomonto Licensing Manager Turkey Point Nuclear Plant Florida Power & Light Company 9762 SW 344th Street Florida City, FL 33035